ClinicalTrials.Veeva

Menu

To Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC

F

Fujian Provincial Cancer Hospital

Status

Completed

Conditions

Nasopharyngeal Carcinoma

Treatments

Radiation: modified reduce-volume target IMRT

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a retrospective real-world study to evaluate the efficacy and feasibility of modified reduce-volume target IMRT in the treatment of patients with non-metastatic NPC

Enrollment

471 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Pathologic diagnosis (pathologically confirmed by nasopharyngeal biopsy) was nasopharyngeal carcinoma;
  2. Newly diagnosed, non-metastatic and treated with modified reduce-volume IMRT;
  3. Patients with baseline MRI date of nasopharynx and neck, and completed the first course of treatment in our hospital;
  4. Diagnosis time: November 1, 2014 to December 31 , 2017

Exclusion criteria

  1. Disease progression during IMRT;
  2. Previous malignancy or other concomitant malignant diseases;
  3. The evaluation information of tumor efficacy can not be obtained;
  4. Receive blind treatment in other clinical research.

Trial design

471 participants in 1 patient group

Modified reduce-volume target IMRT
Description:
Patients with newly diagnosed, non-metastatic NPC was given modified reduce-volume target IMRT
Treatment:
Radiation: modified reduce-volume target IMRT

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems